AUROBINDO PHARMA LIMITED

AUROPHARMA.NS
Exchange NSI, Currency in INR
Loading price...

Overview

Previous Close1,668.4
Open1,666.7
Ask0
Bid0
Day's Range1,655.5 - 1,681.4
52 Week Range1,066.8 - 1,717
PE Ratio(TTM)26.22
Market Cap₹96,652Cr
Volume₹4,94,131
Avg. Volume₹11,24,509
Face Value--
Dividend Yield0.24%

Analyst Consensus

Rating Breakdown (27 analysts)
Strong Buy: 5Buy: 13Hold: 5Sell: 2Strong Sell: 2

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARS
No results to display

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
HQ Location: Hyderabad, India
Website: https://www.aurobindo.com
undefined:
Employees: 29,209
About Company:
Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products. The company was incorporated in 1986 and is headquartered in Hyderabad, India.